6 papers in the library · 20 citations · publishing 2024-2025
September 1, 2025 Franklin King Iv
After completing this activity, participants should be able to: Differentiate between the regulatory status, therapeutic applications, and clinical considerations of various psychedelic substances. Recognize and manage the safety considerations and potential risks associated with psychedelic-assisted therapy. Apply harm reduction principles when counseling patients who express interest in...
Journal of immigrant and minority health June 9, 2025 Juliana Zambrano, Fernando Espí Forcén, Jose Hidalgo et al.
Despite increasing interest in psychedelic-assisted therapies (PAT), there remains a critical gap in extending these treatments to marginalized and vulnerable populations, including Latinx immigrants. This underrepresentation in both research and clinical practice exacerbates disparities in mental health care access for racial and ethnic minorities, who already face systemic barriers. The...
Psychedelic Intersections January 17, 2025 Franklin King Iv
Psychedelics can evoke powerful projections not only for those under the influence of these substances but also for those who study them. As Timothy Leary once quipped, “LSD [is a psychedelic drug that] occasionally causes psychotic behavior in people who have not taken it.” This speaks to how the idea of psychedelics can be polarizing, political, and often poorly defined. While psychedelic...
Psychopharmacology 2025 Brian S. Barnett, M Frances Vest, Marcus S Delatte et al. 20 citations
There is increasing interest in establishing psychedelic research programs at academic medical centers. However, psychedelics are intensely psychoactive, carry considerable sociopolitical baggage, and most are Schedule I drugs, creating significant potential impediments to implementation. There is little formal guidance for investigators on navigating the complex on-the-ground obstacles...
September 1, 2024 Franklin King Iv
Differentiate between classic psychedelics and their mechanisms of action. Describe how psychedelics influence brain networks, particularly the default mode network, and explain the potential therapeutic implications of these effects on conditions like depression. Outline the key components of psychedelic-assisted therapy, including preparation, support during the psychedelic session, and...
August 30, 2024 Franklin King Iv
Psychedelics have been used therapeutically for thousands of years by various cultures, and the term "novel therapeutic agent" should not describe them. The classic psychedelics are mainly tryptamines (e.g., psilocybin, DMT, LSD) and phenethylamines (e.g., MDMA, mescaline, 2C-B), with tryptamines being more studied currently. While most psychedelics are medically safe, some like ibogaine and...